Skip to main content

Chemistry in the Pharmaceutical Industry

  • Chapter
  • First Online:
Handbook of Industrial Chemistry and Biotechnology

Abstract

This chapter discusses the role of chemistry within the pharmaceutical industry. Although the focus is upon the industry within the United States, much of the discussion is equally relevant to pharmaceutical companies based in other nations, for example Japan and those in Europe. The primary objective of the pharmaceutical industry is the discovery, development, and marketing of safe and efficacious drugs for the treatment of human disease. However, drug companies must earn profits in order to remain viable and finance the essential research and development that leads to new drugs designed to address unmet medical need. Thus, there exists a tension between the dual goals of enhancing the quality and duration of human life and increasing stockholder or private investor equity. The chapter provides an overview of the processes and activities involved in drug discovery and development with an emphasis on the role of chemists. Examples of marketed drugs are provided and are organized by the major disease areas. Several important drug discovery strategies and technologies that may be employed when applicable are briefly summarized. A section on process chemistry provides an overview of the topic and then describes some recent actual examples. Despite the considerable benefits provided by therapeutic agents discovered to date, there remains considerable unmet medical need in many disease areas. Pharmaceutical research will continue to be challenging but it is anticipated that creative medicinal, analytical, and process chemists will be needed at the forefront to enable the future discovery of new medicines and to bring improvements to the overall effectiveness of the field.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 549.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 699.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Krogsgaard-Larsen, P., Liljefors, T., Madsen, U. (Eds.) (1996) A textbook of drug design and development, 2, Harwood Academic, Amsterdam.

    Google Scholar 

  2. Spilker B (1989) Multinational drug companies; issues in drug discovery and development. Raven Press, New York

    Google Scholar 

  3. Wermuth CG (ed) (1996) The practice of medicinal chemistry. Academic, San Diego

    Google Scholar 

  4. Wess G, Urmann M, Sickenberger B (2001) Angew Chem Int Ed 40:3341–3350

    Article  CAS  Google Scholar 

  5. Lipinski CA, Lombardo F, Dominy DW, Feeny PJ (1997) Adv Drug Deliv Rev 23:3–25

    Article  CAS  Google Scholar 

  6. Stella VJ, Borchardt RT, Hageman MJ, Oliyai R, Maag H, Tilley JW (eds) (2007) Prodrugs: challenges and rewards, Parts 1 and 2. Springer, New York

    Google Scholar 

  7. Gauwerky K, Borelli C, Korting HC (2009) Drug Discov Today 14:214–222

    Article  CAS  Google Scholar 

  8. Miertus S, Fassina G (eds) (1999) Combinatorial chemistry and technology: principles, methods and applications. Marcel Dekker Inc, New York

    Google Scholar 

  9. Dolle R (2001) J Combinatorial Chem 3:477–518

    Article  CAS  Google Scholar 

  10. Franzini RM, Neri D, Scheuermann J (2014) Acc Chem Res 47:1247–1255

    Article  CAS  Google Scholar 

  11. Musumeci F, Schenone S, Desogus A, Nieddu E, Deodato D, Botta L (2015) CurrMed Chem 22:2022–2050

    Article  CAS  Google Scholar 

  12. See International Conference of Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guideline. Impurities in New Drug Substances Q3A (R2): (2006) High dose drugs may require lower impurity limits. http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html

  13. Laird T (2010) Org Process Res Dev 14:942–1045

    Article  CAS  Google Scholar 

  14. See International Conference of Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guideline. Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk M7: (2014) http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html

  15. Gerberick GF, Ryan CA, Dearman RJ, Kimber I (2007) Methods 41:54–60

    Article  CAS  Google Scholar 

  16. Gautheron P, Dukic M, Alix D, Sina J (1992) Fundam Appl Toxicol 18:442–449

    Article  CAS  Google Scholar 

  17. Leonhardt J, Nau M, Wolter M, Rau CJ (2008) Prev Process Ind 21:400–406

    Article  CAS  Google Scholar 

  18. Urben PG (ed) (2007) Bretherick’s handbook of reactive chemical hazards. Butterworth-Heinemann LTD, Jordan Hill, Oxford

    Google Scholar 

  19. Pratt, Thomas H. (July 15, 1997). Electrostatic ignitions of fires and explosions, Wiley-AIChE Center for Chemical Process Safety

    Google Scholar 

  20. Gastroplus is a software application from Simulations Plus, Inc., Lancaster, Ca. which simulates a range of properties including absorption, pharmacokinetics and pharmacodynamics in both animals and humans

    Google Scholar 

  21. Kopach M, Leahy D, Manley J (2012) Innovations Pharm Technol 43:72

    CAS  Google Scholar 

  22. Sá Gomes P, Rodrigues AE (2012) Chem Eng Technol 1:17–34

    Article  Google Scholar 

  23. McConville FX (2007) The pilot plant real book, 2nd edn. FXM Engineering and Design, Worcester, MA

    Google Scholar 

  24. Purandare A, McDevitt TM, Wan H, You D, Penhallow B, Vuppugalla R, Zhang Y, Ruepp SU, Trainor GI, Lombardo L, Pedicord D, Gottardis MM, Ross-Macdonald P, de Silva H, Hosbach J, Emanuel SL, Blat Y, Fitzpatrick E, Taylor TL, McIntyre KW, Michaud E, Mulligan C, Lee FY, Woofson A, Lasho TL, Pardanani A, Tefferi A, Lorenzi MV (2012) Leukemia 26:280

    Article  CAS  Google Scholar 

  25. Wei CS, Davies GHM, Soltani O, Albrecht J, Gao Q, Pathirana P, Hsiao Y, Tummala S, Eastgate MD (2013) Angew Chem Int Ed 52:5822–5826

    Article  CAS  Google Scholar 

  26. Foo K, Sella E, Thomé I, Eastgate MD, Baran PS (2014) J Am Chem Soc 136:5279–5282

    Article  CAS  Google Scholar 

  27. Beutner GL, Desai L, Fanfair D, Lobben P, Anderson E, Leung SW, Eastgate MD (2014) Org Process Res Dev 18:1812–1820

    Article  CAS  Google Scholar 

  28. Chen K, Eastgate MD, Zheng B, Li J (2011) Org Process Res Dev 15:886–892

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John F. Kadow .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Kadow, J.F., Meanwell, N.A., Eastman, K.J., Yeung, KS., DelMonte, A.J. (2017). Chemistry in the Pharmaceutical Industry. In: Kent, J., Bommaraju, T., Barnicki, S. (eds) Handbook of Industrial Chemistry and Biotechnology. Springer, Cham. https://doi.org/10.1007/978-3-319-52287-6_8

Download citation

Publish with us

Policies and ethics